Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Pilot Phase I/II Study of the Efficacy and Safety of APD209 in Patients With Cachexia and Advanced Malignancy

NCT00895726 is registered in ClinicalTrials.gov with Acacia Pharma Ltd as lead sponsor.

NCT NCT00895726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00895726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Pilot Phase I/II Study of the Efficacy and Safety of APD209 in Patients With Cachexia and Advanced Malignancy
Lead sponsor
Acacia Pharma Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
January 31, 2012
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cachexia